S.-M. Wong et al. / Tetrahedron Letters 43 (2002) 2299–2302
2301
Scheme 3. Synthesis of 1-methoxy-3-dimethylamino-7-nitronaphthalene 11 and preliminary exploration of the limitations of the
naphthalene-forming condensation reaction. Reagents and conditions: (i) MeC(OMe)2NMe2, MeCONMe2, 150°C, 16 h, 5.3%; (ii)
Hg(OAc)2, aq. NaOH (10%), reflux, 3 days; (iii) I2, aq. NaOH (3.4%), reflux, 16 h; (iv) MeOH, H2SO4, 62% from 14; (v)
PhCH2ZnBr, Bui2AlH, Pd(PPh3)2Cl2, THF, 45°C, 72 h, 32%.
mechanism and generality. This condensation has con-
siderable potential for construction of ‘push-pull’-sub-
stituted polycyclic arenes. The results of a more
comprehensive study on this reaction will be published
later.
as dark red needles; mp 123–124°C; IR wmax 1522, 1343
cm−1; NMR (CDCl3) lH 3.13 (6H, s, NMe2), 4.00 (3H, s,
OMe), 6.48 (1H, d, J=2.3 Hz, 2-H), 7.11 (1H, dd,
J=8.2, 7.8 Hz, 7-H), 7.37 (1H, d, J=2.3 Hz, 4-H), 8.24
(1H, dd, J=7.8, 1.2 Hz, 8-H), 8.37 (1H, dd, J=8.2, 1.2
Hz, 6-H); MS (EI) m/z 246 (M). Found: C, 63.4; H, 5.72;
N, 11.4. C13H14N2O3 requires C, 63.41; H, 5.69; N,
11.38%.
Acknowledgements
10. Gate, E. N.; Meek, M. A.; Schwalbe, C. H.; Stevens, M.
F. G.; Threadgill, M. D. J. Chem. Soc., Perkin Trans. 2
1985, 251.
11. Schurman, J. V.; Becker, E. I. J. Org. Chem. 1953, 18,
211.
12. Friedla¨nder, P.; Szymanski, S. Chem. Ber. 1892, 25, 2076.
13. Machida, M.; Bando, M.; Migata, Y.; Machida, M. I.;
Kanaoka, Y. Chem. Pharm. Bull. 1976, 24, 3045.
14. Gould, R. G.; Jacobs, W. A. J. Biol. Chem. 1939, 130,
407.
We thank Mr. R. R. Hartell and Mr. D. J. Wood for
the NMR spectra and Mr. C. Cryer for the mass
spectra. J.A.W. held a Research Studentship from the
Department of Pharmacy & Pharmacology, University
of Bath. Part of this work was carried out by S.-M.W.,
B.S., P.S. and I.C.B. as an Undergraduate Research
Project for the MPharm degree.
15. Data for 8: Mp 62–65°C; IR (KBr) wmax 2186, 1724, 1524,
1363 cm−1; NMR ((CD3)2SO) lH 2.40 (3H, s, Me), 7.56
(1H, dd, J=8.2, 7.8 Hz, 5-H), 8.00 (1H, d, J=7.8 Hz,
6-H), 8.04 (1H, d, J=8.2 Hz, 4-H). Found: C, 54.4; H,
4.59; N, 7.05. C9H6D3NO4 requires C, 54.5; H, 4.54; N,
7.07%.
References
1. Bailey, A. S.; Shuttleworth, A. J. J. Chem. Soc. C 1968,
1115.
2. House, H. O.; Koepsell, D. G.; Campbell, W. J. J. Org.
Chem. 1972, 37, 1003.
3. Sepiol, J. J.; Wilamowski, J. Tetrahedron Lett. 2001, 42,
5287.
16. Phadnis, A. P.; Nanda, B.; Patwardhan, S. A.; Gupta, A.
S. Indian J. Chem. B 1984, 23, 1098.
17. Data for 11: Dark red needles; mp 172–174°C; NMR
(CDCl3) lH 3.15 (6H, s, NMe2), 4.03 (3H, s, OMe), 6.52
(1H, brs, 2-H), 6.56 (1H, brs, 4-H), 7.54 (1H, d, J=9.5
Hz, 5-H), 8.08 (1H, dd, J=9.5, 2.6 Hz, 6-H), 9.00 (1H, d,
J=2.6 Hz, 8-H); lC 40.5, 55.5, 95.1, 98.3, 117.0, 120.4,
120.6, 126.0, 138.7, 141.0, 151.8, 158.0; MS (EI) m/z
246.0998 (M) (C13H14N2O3 requires 246.1004). Found: C,
63.2; H, 5.80; N, 11.2. C13H14N2O3 requires C, 63.41; H,
5.69; N, 11.38%.
18. Racine, S. Liebigs Ann. Chem. 1887, 239, 71.
19. Seno, K.; Hagishita, S.; Sato, T.; Kuriyama, K. J. Chem.
Soc., Perkin Trans. 1 1984, 2012.
20. Synthesis of 16. Compound 15 (2.5 g, 8.1 mmol) and
benzyl zinc bromide (0.5 M in THF, 24.5 mL, 12.2 mmol)
in dry THF (30 mL) were added to Pd(PPh3)2Cl2 (330
4. Sibi, M. P.; Dankwart, J. W.; Snieckus, V. J. Org. Chem.
1986, 51, 271.
5. McDonald, M. C.; Mota-Filipe, H.; Wright, J. A.; Abdel-
rahman, M.; Threadgill, M. D.; Thompson, A. S.;
Thiemermann, C. Br. J. Pharmacol. 2000, 130, 843.
6. Parveen, I.; Naughton, D. P.; Whish, W. J. D.; Thread-
gill, M. D. Bioorg. Med. Chem. Lett. 1999, 9, 2031.
7. Somei, M.; Karasawa, Y.; Shoda, T.; Kaneko, C. Chem.
Pharm. Bull. 1981, 29, 249.
8. Rohr, O. US Patent 4048217, 1997.
9. Synthesis of 6. Ester 1a (1.01 g, 5.2 mmol) was heated at
150°C with MeC(OMe)2NMe2 (2.5 g, 18.8 mmol) in
MeCONMe2 (6 mL) for 16 h. Evaporation and chro-
matography (hexane/EtOAc, 10:1) gave 6 (990 mg, 77%)